首页|帕罗西汀联合奥氮平治疗女性抑郁症合并睡眠障碍的效果研究

帕罗西汀联合奥氮平治疗女性抑郁症合并睡眠障碍的效果研究

扫码查看
目的 探讨帕罗西汀联合奥氮平治疗女性抑郁症合并睡眠障碍的效果。方法 98例女性抑郁症合并睡眠障碍患者,参照随机数字表法分为对照组和研究组,每组49例。对照组患者接受帕罗西汀治疗,研究组在对照组基础上联用奥氮平治疗。比较两组患者的临床疗效、匹兹堡睡眠质量指数量表(PSQI)评分、世界卫生组织生存质量测定简表(QOL-BREF)评分以及不良反应发生情况。结果 研究组总有效率93。88%明显高于对照组的77。55%(P<0。05)。治疗前,两组患者PSQI、QOL-BREF评分比较无差异性(P>0。05);治疗3个月后,研究组PSQI评分(8。02±1。20)分低于对照组的(12。85±1。50)分,QOL-BREF评分(90。02±5。00)分高于对照组的(82。65±4。85)分(P<0。05)。两组患者不良反应发生率比较无差异性(P>0。05)。结论 女性抑郁症合并睡眠障碍患者采用帕罗西汀联合奥氮平治疗效果确切,可以有效改善抑郁症状与睡眠障碍症状,保障生活质量,安全性较佳。
Study on the effect of paroxetine combined with olanzapine in the treatment of female depression complicated with sleep disorders
Objective To explore the effect of paroxetine combined with olanzapine in the treatment of female depression complicated with sleep disorders. Methods 98 female patients with depression and sleep disorders were divided into a control group and a study group according to random number table method,with 49 cases in each group. The control group was treated with paroxetine,and the study group was treated with olanzapine on the basis of the control group. The clinical efficacy,Pittsburgh sleep quality index (PSQI),World Health Organization Quality of Life BREF (QOL-BREF) score and the incidence of adverse reactions were compared between the two groups. Results The total effective rate of 93.88% in the study group was significantly higher than 77.55% in the control group (P<0.05). Before treatment,there were no differences in PSQI and QOL-BREF scores between the two groups (P>0.05). After 3 months of treatment,PSQI score of (8.02±1.20) points in the study group was lower than (12.85±1.50) points in the control group,and QOL-BREF score of (90.02±5.00) points was higher than (82.65±4.85) points in the control group (P<0.05). There was no difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion The treatment effect of paroxetine combined with olanzapine for female patients with depression and sleep disorders is definite,which can effectively improve the symptoms of depression and sleep disorders,ensure the quality of life,and have good safety.

ParoxetineOlanzapineFemaleDepressionSleep disorders

沈君、李昌英、朱晓勇、廖东升

展开 >

810007 青海省第三人民医院精神科

帕罗西汀 奥氮平 女性 抑郁症 睡眠障碍

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(20)